CMOPF (Cosmo NV) Operating Margin %: -10.53% (As of Dec. 2025)


CMOPF Cosmo NV CMOPF
82 GF Score
Price $85.45
GF Value $54.86
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cosmo NV Operating Margin %?

Cosmo NV CMOPF +4.87% 82 Operating Margin % is -10.53% as of Dec. 2025. GuruFocus rates CMOPF with a GF Score™ of 82/100 and a GF Value™ of $54.86 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 955 Drug Manufacturers companies, Cosmo NV ranks worse than 77.28% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Cosmo NV's Operating Income for the six months ended in Dec. 2025 was $-6.5 Mil. Cosmo NV's Revenue for the six months ended in Dec. 2025 was $61.4 Mil. Therefore, Cosmo NV's Operating Margin % for the quarter that ended in Dec. 2025 was -10.53%.

The historical rank and industry rank for Cosmo NV's Operating Margin % or its related term are showing as below:

CMOPF' s Operating Margin % Range Over the Past 10 Years
Min: -25.33   Med: 8.98   Max: 55.58
Current: -6.65


CMOPF's Operating Margin % is ranked worse than
77.28% of 955 companies
in the Drug Manufacturers industry
Industry Median: 7.45 vs CMOPF: -6.65

Cosmo NV's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Cosmo NV's Operating Income for the six months ended in Dec. 2025 was $-6.5 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was $-8.1 Mil.


Cosmo NV  (OTCPK:CMOPF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Cosmo NV Operating Margin % Related Terms


Cosmo NV Operating Margin % Historical Data

* Premium members only.

The historical data trend for Cosmo NV's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo NV Operating Margin % Chart

Cosmo NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.06 27.48 6.63 55.58 -6.66

Cosmo NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.97 57.80 53.26 -2.73 -10.53

CMOPF vs LLY, JNJ, ABBV: Operating Margin % Comparison

For the Drug Manufacturers - General subindustry, Cosmo NV's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmo NV Operating Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cosmo NV's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Cosmo NV's Operating Margin % falls into.


CMOPF
82GF Score
Cosmo NV CMOPF
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosmo NV Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Cosmo NV's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-8.122 / 121.984
=-6.66 %

Cosmo NV's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-6.47 / 61.422
=-10.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -10.53% mean?
Cosmo NV (CMOPF) has a Operating Margin % of -10.53% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Cosmo NV and its competitors. According to the industry distribution chart, Cosmo NV ranks #738 out of 955 companies in the Drug Manufacturers industry, placing it in the top 77.3%.
Is Cosmo NV's Operating Margin % too high?
Cosmo NV's current Operating Margin % is -10.53%. Based on the distribution chart, Cosmo NV ranks #738 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cosmo NV has a GF Score™ of 82/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cosmo NV's Operating Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Cosmo NV ranks #738 out of 955 companies for Operating Margin %. This places Cosmo NV in the lower half of its industry. The industry median Operating Margin % is 7.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Cosmo NV and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmo NV's current Operating Margin % is -10.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo NV stock overvalued right now?
Based on GuruFocus' analysis, Cosmo NV (CMOPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $54.86, compared to a current price of $85.45 — trading 55.8% above its estimated fair value. The current Operating Margin % is -10.53%. Cosmo NV's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Cosmo NV (CMOPF), the current Operating Margin % is -10.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo NV (CMOPF) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo NV stock appears to be overvalued. The current stock price of $85.45 is trading 55.8% above its estimated GF Value™ of $54.86. GuruFocus considers Cosmo NV to be Significantly Overvalued.

Key valuation signals for CMOPF:

  • Operating Margin %: -10.53%
  • GF Value™: $54.86 vs. price of $85.45 (55.8% above fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the CMOPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cosmo NV Business Description

Address 91/94 North Wall Quay, 7th Floor, One North Dock, Dublin, IRL, D01 H7V7
Cosmo NV is is a life sciences company. The company is focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). The company designs, develops, and manufactures solutions to address critical medical needs. Its technologies are trusted by international pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. The product pipeline includes Eleview, GI Genius, Winlevi, Lialda, Uceris, and others.
82GF Score

Get the complete analysis for CMOPF

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$85.45
Price
$54.86
GF Value